Ledger.Open graph →
SEC Form D · filed February 28, 2022

Osmol Therapeutics, Inc

Offering
$7.5M
Sold
$2.3M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (8)

Robert Linke · New Haven, CTExec · DirectorVlad Coric · New Haven, CTDirectorMichael Ehrlich · New Haven, CTDirectorRobert Berman · Santa Monica, CADirectorMichael Ehrlich · New Haven, CTDirectorRobert Berman · New Haven, CTDirectorRobert Linke · Sudbury, MAExec · DirectorVlad Coric · New Haven, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗